The Outcomes of Laparoscopic Hybrid Surgery Versus Totally Open Surgery
- Conditions
- Resectable Simultaneous Colorectal Cancer Liver Metastasis
- Interventions
- Procedure: laparoscopic hybrid surgery (LHS)
- Registration Number
- NCT06550700
- Lead Sponsor
- Changhai Hospital
- Brief Summary
Simultaneous colorectal cancer liver metastasis (SCRLM) is one of the risk factors for poor prognosis in colorectal cancer. Surgical resection of primary and metastatic lesions is the first choice of treatment for patients with resectable SCRLM. Simultaneous resection of colorectal cancer liver metastases by totally open surgery (TOS) has been widely used. However, we propose that laparoscopic hybrid surgery (LHS) may have better short and long-term outcomes. This study aimed to compare the safety, short-term, and long-term efficacy of LHS versus TOS for patients with resectable SCRLMs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 266
- Liver metastasis was detected while the colorectal cancer was diagnosed.
- Both the primary lesions and liver metastases were confirmed by postoperative pathological examination.
- Clinical data is complete.
- Patients with unresectable extrahepatic metastases.
- Patients with other malignant tumor diseases that have not been cured.
- Clinical and pathological data were missed or incomplete follow-up data.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description laparoscopic hybrid surgery (LHS) cohort laparoscopic hybrid surgery (LHS) Routine colorectal surgery is performed first, followed by liver surgery. The LHS cohort first performed the laparoscopic exploration of the entire abdominal-pelvic cavity to determine the resectability of the primary and metastatic lesions. After the blood vessel detachment and bowel detachment, the distal bowel of the tumor was severed and the pneumoperitoneum was closed. The liver metastases were then removed in both cohorts by open resection through the right subcostal incision.
- Primary Outcome Measures
Name Time Method short-term outcome: Operative time Within one week of the patient undergoing surgery Time taken for surgery
short-term outcome: Postoperative hospital stay Within one week of the patient undergoing surgery Length of stay of patients after surgery
short-term outcome: Surgical complications Within one week of the patient undergoing surgery Complications that occur in patients after surgery
short-term outcome: Blood loss Within one week of the patient undergoing surgery Patient haemorrhage during surgery
short-term outcome: Time of liquid diet Within one week of the patient undergoing surgery Time for patients to eat fluids for the first time after surgery
- Secondary Outcome Measures
Name Time Method disease-free survival (DFS) 3years the time after surgical treatment until the first observation of tumor recurrence or death for any reason
overall survival (OS) 3years the time after surgical treatment until death for any reason
Trial Locations
- Locations (1)
Department of Colorectal Surgery in Changhai Hospital
🇨🇳Shanghai, Shanghai, China